Cognition Therapeutics is a clinical-stage biopharmaceutical company leveraging our expertise in the σ-2 (sigma-2) receptor to develop innovative, small molecule therapeutics targeting age-related degenerative diseases. Our initial focus is on degenerative diseases of the CNS and retina such as Alzheimer’s disease, dementia with Lewy bodies and dry age-related macular degeneration.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Jun 23, 2022
Jun 08, 2022
Jun 02, 2022
Jun 16, 2022 at 12:30 PM EDT
Jun 9, 2022 from 10:00 AM to 11:30 AM EDT
May 25, 2022 at 3:30 PM EDT